Greenbaum CJ - Search Results

1

The development and utility of a novel scale that quantifies the glycemic progression toward type 1 diabetes over 6 months.

Sosenko JM, Skyler JS, Beam CA, Boulware D, Mahon JL, Krischer JP, Greenbaum CJ, Rafkin LE, Matheson D, Herold KC, Palmer JP; Type 1 Diabetes TrialNet and Diabetes Prevention Trial–Type 1 Study Groups. Sosenko JM, et al. Among authors: greenbaum cj. Diabetes Care. 2015 May;38(5):940-2. doi: 10.2337/dc14-2787. Epub 2015 Mar 10. Diabetes Care. 2015. PMID: 25758770 Free PMC article.

2

Increased specificity and sensitivity of insulin antibody measurements in autoimmune thyroid disease and type I diabetes.

Hegewald MJ, Schoenfeld SL, McCulloch DK, Greenbaum CJ, Klaff LJ, Palmer JP. Hegewald MJ, et al. Among authors: greenbaum cj. J Immunol Methods. 1992 Sep 18;154(1):61-8. doi: 10.1016/0022-1759(92)90213-d. J Immunol Methods. 1992. PMID: 1401944

3

Improved specificity of ICA assays in the Fourth International Immunology of Diabetes Serum Exchange Workshop.

Greenbaum CJ, Palmer JP, Nagataki S, Yamaguchi Y, Molenaar JL, Van Beers WA, MacLaren NK, Lernmark A. Greenbaum CJ, et al. Diabetes. 1992 Dec;41(12):1570-4. doi: 10.2337/diab.41.12.1570. Diabetes. 1992. PMID: 1446798

4

Fifth International Serum Exchange Workshop for Insulin Autoantibody (IAA) Standardization. The Immunology and Diabetes Workshops and participating laboratories.

Greenbaum CJ, Wilkin TJ, Palmer JP. Greenbaum CJ, et al. Diabetologia. 1992 Aug;35(8):798-800. doi: 10.1007/BF00429105. Diabetologia. 1992. PMID: 1511809 No abstract available.

5

Insulin autoantibodies measured by radioimmunoassay methodology are more related to insulin-dependent diabetes mellitus than those measured by enzyme-linked immunosorbent assay: results of the Fourth International Workshop on the Standardization of Insulin Autoantibody Measurement.

Greenbaum CJ, Palmer JP, Kuglin B, Kolb H. Greenbaum CJ, et al. J Clin Endocrinol Metab. 1992 May;74(5):1040-4. doi: 10.1210/jcem.74.5.1569152. J Clin Endocrinol Metab. 1992. PMID: 1569152

6

Insulin antibodies and insulin autoantibodies.

Greenbaum CJ, Palmer JP. Greenbaum CJ, et al. Diabet Med. 1991 Feb-Mar;8(2):97-105. doi: 10.1111/j.1464-5491.1991.tb01553.x. Diabet Med. 1991. PMID: 1827408 Review. No abstract available.

7

Nonprogression of subclinical beta-cell dysfunction among first-degree relatives of IDDM patients. 5-yr follow-up of the Seattle Family Study.

McCulloch DK, Klaff LJ, Kahn SE, Schoenfeld SL, Greenbaum CJ, Mauseth RS, Benson EA, Nepom GT, Shewey L, Palmer JP. McCulloch DK, et al. Among authors: greenbaum cj. Diabetes. 1990 May;39(5):549-56. doi: 10.2337/diab.39.5.549. Diabetes. 1990. PMID: 2185106

8

Prospective evaluation of beta-cell function in insulin autoantibody-positive relatives of insulin-dependent diabetic patients.

Neifing JL, Greenbaum CJ, Kahn SE, McCulloch DK, Barmeier H, Lernmark A, Palmer JP. Neifing JL, et al. Among authors: greenbaum cj. Metabolism. 1993 Apr;42(4):482-6. doi: 10.1016/0026-0495(93)90107-y. Metabolism. 1993. PMID: 8487672

9

Nicotinamide's effects on glucose metabolism in subjects at risk for IDDM.

Greenbaum CJ, Kahn SE, Palmer JP. Greenbaum CJ, et al. Diabetes. 1996 Nov;45(11):1631-4. doi: 10.2337/diab.45.11.1631. Diabetes. 1996. PMID: 8866571 Clinical Trial.

10

Relationship of beta-cell function and autoantibodies to progression and nonprogression of subclinical type 1 diabetes: follow-up of the Seattle Family Study.

Greenbaum CJ, Sears KL, Kahn SE, Palmer JP. Greenbaum CJ, et al. Diabetes. 1999 Jan;48(1):170-5. doi: 10.2337/diabetes.48.1.170. Diabetes. 1999. PMID: 9892239

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

247 results

Search Page